Pediatrix Medical Group, Inc. (MD)

Pediatrix Medical Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	150.09	165.39	-99.07	-60.41	66.34	130.96
Depreciation & Amortization	23.78	21.83	32.23	36.17	35.64	32.15
Loss (Gain) From Sale of Assets	-	-20.91	9.7	-	-	-7.28
Asset Writedown & Restructuring Costs	-	-	178.44	148.31	-	-
Loss (Gain) From Sale of Investments	-	-	-	20	-	-
Stock-Based Compensation	21.28	18.05	11.87	12.32	16.13	18.97
Other Operating Activities	54.37	48.56	-4.15	1.31	32.39	-37.67
Change in Accounts Receivable	-0.7	30.56	10.29	26.28	-5.54	-72.73
Change in Accounts Payable	-7.28	28.33	51.14	-11.92	0.42	21.33
Change in Income Taxes	-5.51	-1.21	-5.04	-21.68	18.23	-2.29
Change in Other Net Operating Assets	-6.89	-15.85	31.84	-4.31	18.73	30.32
Operating Cash Flow	226.89	271.09	206.57	137.33	166.94	76.74
Operating Cash Flow Growth	-21.76%	31.23%	50.43%	-17.74%	117.55%	-62.50%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-17.29	-18.46	-22.02	-33.33	-29.71	-32.25
Sale of Property, Plant & Equipment	-	-	-	-	-	24.73
Cash Acquisitions	-11	-23.2	-8.17	-6.67	-28.17	-29.93
Divestitures	-	30	-	-	-	-
Investment in Securities	6.76	-3.18	-12.05	-8.99	-0.46	-18.56
Other Investing Activities	0.65	-3.47	6.84	0.81	1.38	2.93
Investing Cash Flow	-20.88	-18.3	-35.41	-48.18	-56.95	-53.07

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Issued	-	-	235.5	470	1,480	-
Long-Term Debt Repaid	-	-20.75	-250.89	-489.12	-1,885	-762.66
Net Debt Issued (Repaid)	-25.2	-20.75	-15.39	-19.12	-405.17	-762.66
Issuance of Common Stock	2.94	3.18	3.64	4.91	5.4	6.85
Repurchase of Common Stock	-211.28	-86.68	-1.7	-0.92	-88.51	-4.72
Other Financing Activities	-0.6	-3.25	-1.03	-10.59	0.73	0.41
Financing Cash Flow	-234.14	-107.49	-14.49	-25.72	-487.55	-760.12

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	-28.14	145.3	156.68	63.43	-377.57	-736.45

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	209.59	252.63	184.55	104	137.23	44.49
Free Cash Flow Growth	-23.34%	36.89%	77.46%	-24.22%	208.47%	-74.70%
Free Cash Flow Margin	10.70%	13.20%	9.17%	5.21%	6.96%	2.33%
Free Cash Flow Per Share	2.56	2.96	2.21	1.26	1.63	0.52
Levered Free Cash Flow	141.31	190.33	173.92	69.2	136.08	61.19
Unlevered Free Cash Flow	162.13	212.81	199.39	95.5	160.89	104.14

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	34.38	34.38	40	42.28	116.24	86.54
Cash Income Tax Paid	1.72	1.72	4.7	30.8	26.91	54.73
Change in Working Capital	-20.37	41.83	88.24	-11.63	31.83	-23.37

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 4, 2026

Data Sources Report a data error